Pages that link to "Q53295548"

The following pages link to The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. (Q53295548):

Displaying 47 items.

• FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance (Q26864654) (← links)
• F-box protein FBXL2 inhibits gastric cancer proliferation by ubiquitin-mediated degradation of forkhead box M1 (Q28118130) (← links)
• Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia (Q28478143) (← links)
• The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer (Q30010104) (← links)
• Postnatal development, maturation and aging in the mouse cochlea and their effects on hair cell regeneration (Q30442295) (← links)
• Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line (Q31105943) (← links)
• MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1 (Q33587320) (← links)
• Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers (Q33723151) (← links)
• SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells (Q33907729) (← links)
• Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition (Q34649774) (← links)
• Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models (Q35045311) (← links)
• Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. (Q35068076) (← links)
• Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia (Q35197045) (← links)
• FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. (Q35800767) (← links)
• Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia (Q36015007) (← links)
• Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas (Q36083264) (← links)
• FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs (Q36094104) (← links)
• Cell cycle control in acute myeloid leukemia. (Q36206479) (← links)
• Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line. (Q36495922) (← links)
• FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c. (Q36576225) (← links)
• Novel functions of FoxM1: from molecular mechanisms to cancer therapy (Q36657633) (← links)
• miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer (Q36729390) (← links)
• Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma (Q36882572) (← links)
• MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. (Q37098261) (← links)
• Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors (Q37348740) (← links)
• Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms. (Q38268221) (← links)
• Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance. (Q38270775) (← links)
• FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis (Q38693990) (← links)
• Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma (Q38815782) (← links)
• FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target (Q38820614) (← links)
• Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells (Q38960718) (← links)
• Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer (Q38977601) (← links)
• Roles of FoxM1 in cell regulation and breast cancer targeting therapy (Q39125526) (← links)
• Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma (Q39407261) (← links)
• JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia (Q39442399) (← links)
• Small GTPase RAB45-mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells (Q39479715) (← links)
• Prognostic significance of FoxM1 expression in non-small cell lung cancer (Q39689018) (← links)
• FOXM1 coming of age: time for translation into clinical benefits? (Q41859224) (← links)
• Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effect (Q43461214) (← links)
• Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer. (Q46458100) (← links)
• FoxM1 is associated with metastasis in colorectal cancer through induction of the epithelial-mesenchymal transition (Q47123091) (← links)
• Nuclear FOXM1 drives chemoresistance in AML. (Q51439944) (← links)
• FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial‑mesenchymal transition (Q64113867) (← links)
• FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML (Q89747558) (← links)
• Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells (Q92015814) (← links)
• Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics (Q92987750) (← links)
• The Role of Forkhead Box Proteins in Acute Myeloid Leukemia (Q92989510) (← links)